Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis
Journal of Investigative Dermatology · 2023-05 · 143 (5) · 777-789.e6
DOI: 10.1016/j.jid.2022.10.021 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Investigative Dermatology, 2023-05. Verfasst von Ji Hae Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea. Hauptthemen laut MEDLINE: Vitiligo, Sjogren's Syndrome, Lupus Erythematosus, Systemic, Thyroid Diseases. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 179 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Vitiligo has been reported to be associated with a variety of diseases, but it has not been systematically reviewed. Therefore, we aimed to identify prevalent diseases in patients with vitiligo and quantify their associations compared with those in healthy controls. A comprehensive search of MEDLINE and EMBASE from the inception to June 2022 was conducted. Observational studies on prevalent diseases in patients with vitiligo compared with those in healthy controls were included, whereas studies limited to pediatrics or providing only laboratory results were excluded. A total of 78 studies were eligible for analyses. Patients with vitiligo showed higher risks of having comorbid autoimmune and connective tissue diseases, including alopecia areata (OR = 2.63, 95% confidence interval [CI] = 2.50‒2.78), discoid lupus erythematosus (OR = 2.54, 95% CI = 1.74‒3.72), Sjogren's syndrome (OR = 2.50, 95% CI = 1.98‒3.16), myasthenia gravis (OR = 2.30, 95% CI = 1.74‒3.02), systemic lupus erythematosus (OR = 1.96, 95% CI = 1.52‒2.52), and rheumatoid arthritis (OR = 1.82, 95% CI = 1.55‒2.15). Thyroid diseases, diabetes mellitus, metabolic syndrome, sensorineural hypoacusis, and ophthalmic abnormalities were also more prevalent in patients with vitiligo. In conclusion, vitiligo is associated with various systemic diseases. Physicians should evaluate and manage potential comorbid conditions in patients with vitiligo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
- Department of Dermatology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
- Department of Medicine, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj City, Saudi Arabia.
- Department of Dermatology, Henry Mondor Hospital, Paris Est Créteil University, Créteil, France.
- Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea. Electronic address: jminbae@gmail.com.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, J. H., Ju, H. J., Seo, J. M., Almurayshid, A., Kim, G. M., Ezzedine, K., & Bae, J. M. (2023). Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis. Journal of Investigative Dermatology, 143(5), 777-789.e6. https://doi.org/10.1016/j.jid.2022.10.021
Vancouver
Lee JH, Ju HJ, Seo JM, Almurayshid A, Kim GM, Ezzedine K, et al. Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis. Journal of Investigative Dermatology. 2023;143(5):777-789.e6. doi:10.1016/j.jid.2022.10.021
BibTeX
@article{Lee2023,
author = {Lee, Ji Hae and Ju, Hyun Jeong and Seo, Ji Min and Almurayshid, Abdurrahman and Kim, Gyong Moon and Ezzedine, Khaled and Bae, Jung Min},
title = {Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis},
journal = {Journal of Investigative Dermatology},
year = {2023},
volume = {143},
number = {5},
pages = {777--789.e6},
doi = {10.1016/j.jid.2022.10.021}
}
EUVIMED